Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats

European Journal of Pharmacology
M A CotterN E Cameron

Abstract

Increased polyol pathway flux has been linked to nerve complications in diabetic rats, which are attenuated by aldose reductase inhibitors, defective nitric oxide-mediated vasodilation being a particular target. Diabetes also elevates the endothelial angiotensin system, increasing vasa nervorum vasoconstriction. The aim was to assess whether promotion of vasodilation by treatment with the aldose reductase inhibitor, ZD5522 (3',5'-dimethyl-4'-nitromethylsulphonyl-2-(2-tolyl)acetanilide), coupled with reduced vasoconstriction using the angiotensin-converting enzyme inhibitor, lisinopril, interacted positively to improve neurovascular function. After 8 weeks of streptozotocin-induced diabetes, sciatic nerve blood flow and motor conduction velocity were 51% and 21% reduced, respectively. Two weeks of lisinopril treatment dose-dependently corrected the conduction deficit (ED(50) approximately 0.9 mg kg(-1)). Low-dose lisinopril (0.3 mg kg(-1)) or ZD5522 (0.25 mg kg(-1)) had modest corrective (10-20%) effects on nerve conduction and perfusion. However, when combined, blood flow and conduction velocity reached the nondiabetic range. The ZD5522 dose used gave a approximately 45% nerve sorbitol reduction but had no significant effect on...Continue Reading

References

Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Feb 1, 1993·Journal of Cardiovascular Pharmacology·B TesfamariamR A Cohen
Sep 1, 1994·Diabetologia·S TesfayeJ D Ward
Feb 1, 1996·Journal of Cardiovascular Pharmacology·A OlbrichS Dhein
Apr 1, 1996·Naunyn-Schmiedeberg's Archives of Pharmacology·V ArchibaldN E Cameron
Jan 1, 1997·Journal of Diabetes and Its Complications·E K MaxfieldM A Cotter
Aug 1, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·G K Oriji, H R Keiser
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·P J PaganoM T Quinn
Jun 26, 1998·British Journal of Pharmacology·A AckermannC González
Sep 18, 1999·Free Radical Biology & Medicine·A KeeganN E Cameron
Dec 10, 1999·Diabetes Research and Clinical Practice·N E Cameron, M A Cotter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.